Showing results (201-210 of 5,974) with videos related to
Sort By:
Pageof 598
Journal of Applied Behavior Analysis|January 31, 2003
Feedback and its effectiveness in a computer-aided personalized system of instruction courseToby L Martin, Joseph J Pear, Garry L MartinCancer Letters|May 8, 2012
CYP1B1 and hormone-induced cancerKetan Gajjar, Pierre L Martin-Hirsch, Francis L MartinMolecular Neurodegeneration|May 3, 2018
Vibrational spectroscopy: a promising approach to discriminate neurodegenerative disordersMaria Paraskevaidi, Pierre L Martin-Hirsch, Francis L MartinCarcinogenesis|February 20, 2021
The evolving role of MUC16 (CA125) in the transformation of ovarian cells and the progression of neoplasiaPanagiotis Giamougiannis, Pierre L Martin-Hirsch, Francis L MartinAmerican Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 25, 2002
Predictors of ARF after cardiac surgical proceduresKatherine R Tuttle, Neil K Worrall, Lynn R Dahlstrom, et al.Cancer Research|September 1, 1984
Interferon-alpha therapy of renal cancerJ A Neidhart, M M Gagen, D Young, et al.Kidney Medicine|January 10, 2024
Clinical Characteristics and Histopathology in Adults With Focal Segmental GlomerulosclerosisKatherine R Tuttle, Clint W Abner, Patrick D Walker, et al.Investigational New Drugs|November 1, 1992
Phase I evaluation of 773U82-HCl in a two-hour infusion repeated daily for three daysH Bailey, P Kohler, R Tuttle, et al.Diabetes, Obesity & Metabolism|October 22, 2016
Effects of once-weekly dulaglutide on kidney function in patients with type 2 diabetes in phase II and III clinical trialsKatherine R Tuttle, T Dwight McKinney, Jaime A Davidson, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 8, 2024
SGLT2 inhibitors and nephrolithiasis risk: a meta-analysisMehmet Kanbay, Crischentian Brinza, Sidar Copur, et al.Pageof 598